During the past decade, National Cancer Institute conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 12 clinical trials were completed, i.e. on average, 32.4% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 10 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Cancer Institute" #1 sponsor was "National Cancer Institute, Lithuania" with 5 trials, followed by "Bayer" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Ipsen" with 4 trials sponsored and "Vilnius University" with 4 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Cancer Institute" #1 collaborator was "Alesund Hospital" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Erasmus Medical Center" with 2 trials as a collaborator, "Gävle Hospital" with 2 trials as a collaborator and "Haukeland University Hospital" with 2 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "National Cancer Institute" are "Gastric Cancer" (4 trials), "Lung Cancer" (3 trials), "Prostate Cancer" (3 trials), "Cancer" (2 trials) and "Carcinoma, Non-Small-Cell Lung" (2 trials). Many other conditions were trialed in "National Cancer Institute" in a lesser frequency.

Most popular intervention types in "National Cancer Institute" are "Drug" (37 trials), "Other" (7 trials), "Biological" (4 trials), "Procedure" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Atezolizumab" (3 trials), "Paclitaxel" (3 trials), "Bevacizumab" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Cancer Institute" are 33 trials for "All" genders, 12 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "National Cancer Institute". undefined are not yet recruiting, 12 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in National Cancer Institute, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in National Cancer Institute, 6 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".

National Cancer Institute has several departments that took part in Clinical trials: "National Cancer Institute; Department of Thoracic Surgery and Oncology" - 2 trials